Improving Access to Care for Veterans With Memory Loss

Veterans Affairs (VA) Pittsburgh Healthcare System

Status: Enrolling

Conditions: Alzheimer Disease

Treatments: Other: ADRD Care Delivery Protocol

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT07117162

1850695

Details and patient eligibility

About

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score >7
• Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD
• Enrolled in VA care
• Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
• Has a working telephone
• 18 years and older
• Able to communicate in English
• Willing to give informed consent.

Exclusion criteria

• None

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

ADRD Care Delivery Protocol

Experimental group

Description:

Patients will undergo telehealth preparedness assessment, cognitive screening, and blood biomarker testing prior to the initial consultation with the specialist.

Treatment:

Other: ADRD Care Delivery Protocol

Usual Care

No Intervention group

Description:

Patients will undergo usual care with all evaluation and testing at the discretion of the specialist.